D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 112 Citations 51,832 638 World Ranking 2251 National Ranking 1328

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

His primary areas of study are Radiation therapy, Internal medicine, Oncology, Surgery and Radiosurgery. His Radiation therapy study integrates concerns from other disciplines, such as Lung cancer, Randomized controlled trial, Metastasis and Nuclear medicine. His Internal medicine study frequently links to related topics such as Glioma.

His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial, Multivariate analysis, Retrospective cohort study, Temozolomide and Neurocognitive. His Surgery research is multidisciplinary, incorporating perspectives in Hippocampal formation and Cancer. His work carried out in the field of Radiosurgery brings together such families of science as Brain metastasis, Survival rate, Combined Modality Therapy, Salvage therapy and Performance status.

His most cited work include:

  • Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial (1817 citations)
  • A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (1528 citations)
  • Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases (830 citations)

What are the main themes of his work throughout his whole career to date?

Minesh P. Mehta spends much of his time researching Internal medicine, Oncology, Radiation therapy, Surgery and Nuclear medicine. In general Internal medicine study, his work on Temozolomide, Clinical trial and Chemotherapy often relates to the realm of In patient, thereby connecting several areas of interest. His Oncology research incorporates elements of Glioma, Neurocognitive, Newly diagnosed and Phases of clinical research.

The Radiation therapy study combines topics in areas such as Cancer, Lung cancer and Randomized controlled trial. His research in Surgery intersects with topics in Metastasis and Incidence. In Nuclear medicine, Minesh P. Mehta works on issues like Tomotherapy, which are connected to Medical physics.

He most often published in these fields:

  • Internal medicine (44.55%)
  • Oncology (41.46%)
  • Radiation therapy (36.51%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (44.55%)
  • Oncology (41.46%)
  • Radiation therapy (36.51%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Oncology, Radiation therapy, Radiology and Radiosurgery are his primary areas of study. His work in the fields of Internal medicine, such as Temozolomide and Clinical trial, intersects with other areas such as In patient. His work is dedicated to discovering how Clinical trial, Hazard ratio are connected with Proportional hazards model and other disciplines.

His Oncology research includes themes of Newly diagnosed, Clinical endpoint, Cohort and Phases of clinical research. His Radiation therapy study is associated with Surgery. Minesh P. Mehta studied Radiosurgery and Metis that intersect with INFRATENTORIAL BRAIN.

Between 2016 and 2021, his most popular works were:

  • Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) (254 citations)
  • Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (107 citations)
  • Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA). (100 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

Minesh P. Mehta mainly focuses on Internal medicine, Oncology, Radiation therapy, Clinical trial and Glioblastoma. His Internal medicine study frequently draws connections between adjacent fields such as Surgery. His Surgery research is multidisciplinary, relying on both Adverse effect and Esophageal cancer.

His Oncology study combines topics from a wide range of disciplines, such as Toxicity, Proportional hazards model, Retrospective cohort study and Hazard ratio. His Radiation therapy research integrates issues from Randomized controlled trial and Disease. His research integrates issues of Tumor progression, Meningioma, Intermediate risk and Intensive care medicine in his study of Clinical trial.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

David W Andrews;Charles B Scott;Paul W Sperduto;Adam E Flanders.
The Lancet (2004)

2510 Citations

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)

2085 Citations

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu.
Journal of Clinical Oncology (2012)

1091 Citations

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins.
Journal of Clinical Oncology (2013)

927 Citations

A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

Paul W. Sperduto;Brian Berkey;Laurie E. Gaspar;Minesh Mehta.
International Journal of Radiation Oncology Biology Physics (2008)

912 Citations

Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial

Vinai Gondi;Stephanie L. Pugh;Wolfgang A. Tome;Chip Caine.
Journal of Clinical Oncology (2014)

899 Citations

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo.
International Journal of Radiation Oncology Biology Physics (2009)

886 Citations

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp.
Journal of Clinical Oncology (2008)

849 Citations

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp.
Journal of Clinical Oncology (2013)

701 Citations

American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.

Louis Potters;Brian Kavanagh;James M. Galvin;James M. Hevezi.
International Journal of Radiation Oncology Biology Physics (2004)

652 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Minesh P. Mehta

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 242

Michael Weller

Michael Weller

University of Zurich

Publications: 198

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 179

David A. Reardon

David A. Reardon

Harvard University

Publications: 145

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 130

Paul D. Brown

Paul D. Brown

Mayo Clinic

Publications: 120

John H. Suh

John H. Suh

Cleveland Clinic

Publications: 120

Michael A. Vogelbaum

Michael A. Vogelbaum

Cleveland Clinic

Publications: 117

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 115

Arjun Sahgal

Arjun Sahgal

Sunnybrook Health Science Centre

Publications: 115

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 112

Matthias Preusser

Matthias Preusser

Medical University of Vienna

Publications: 110

Douglas Kondziolka

Douglas Kondziolka

New York University

Publications: 102

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 101

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 98

Roger Stupp

Roger Stupp

Northwestern University

Publications: 94

Something went wrong. Please try again later.